CytRx Corp. buy melinda
Start price
08.08.17
/
50%
€3.52
Target price
20.09.17
€4.33
Performance (%)
-30.90%
End price
20.09.17
€2.44
Summary
This prediction ended on 20.09.17 with a price of €2.44. The BUY prediction by melinda for CytRx Corp. performed very badly with a performance of -30.90%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CytRx Corp. | - | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by melinda for this prediction
In the thread CytRx Corp. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$
(Vom Mitglied beendet)